drugset / Trial / NCT03805607

IV Ketorolac on Platelet Function Post-Cesarean Delivery

NCT03805607

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Cesarean delivery has become the most common surgical procedure in the US. Non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to improve the quality of post-cesarean analgesia and markedly reduce opioid consumption. The effect of NSAIDs on healthy volunteers results in inhibition of platelet aggregation and prolonged bleeding time. However, in the obstetric population, the presence and degree of platelet inhibition after NSAID exposure is less clear. The investigators plan to use Platelet Aggregometry and Thromboelastography (TEG) to evaluate the effect of ketorolac on platelets.

Timeline

Start
2021-01-18
Primary completion
2022-02-03
Completion
2024-03-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified 30 mg Intravenous